Effects of canagliflozin on brain natriuretic peptide levels in patients with type 2 diabetes on peritoneal dialysis in Japan: protocol for a multicentre, prospective, randomised controlled trial (CARD-PD trial).

Matsuoka N, Nakazawa D, Nishio S, Cho KY, Maoka T, Kaneshima N, Yamamoto R, Yamamoto J, Shimamoto M, Makita M, Iriuda S, Igarashi K, Ito Y, Kato A, Yoshikawa J, Kudo T, Nagashima T, Ito YM, Atsumi T

Open source

DOI: 10.1136/bmjopen-2024-084846
Published: 2024 Nov 25
Container: BMJ open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2024-084846,
  title = {Effects of canagliflozin on brain natriuretic peptide levels in patients with type 2 diabetes on peritoneal dialysis in Japan: protocol for a multicentre, prospective, randomised controlled trial (CARD-PD trial).},
  author = {Matsuoka N and Nakazawa D and Nishio S and Cho KY and Maoka T and Kaneshima N and Yamamoto R and Yamamoto J and Shimamoto M and Makita M and Iriuda S and Igarashi K and Ito Y and Kato A and Yoshikawa J and Kudo T and Nagashima T and Ito YM and Atsumi T},
  year = {2024},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2024-084846},
  url = {https://doi.org/10.1136/bmjopen-2024-084846}
}

RIS

TY  - JOUR
TI  - Effects of canagliflozin on brain natriuretic peptide levels in patients with type 2 diabetes on peritoneal dialysis in Japan: protocol for a multicentre, prospective, randomised controlled trial (CARD-PD trial).
AU  - Matsuoka N
AU  - Nakazawa D
AU  - Nishio S
AU  - Cho KY
AU  - Maoka T
AU  - Kaneshima N
AU  - Yamamoto R
AU  - Yamamoto J
AU  - Shimamoto M
AU  - Makita M
AU  - Iriuda S
AU  - Igarashi K
AU  - Ito Y
AU  - Kato A
AU  - Yoshikawa J
AU  - Kudo T
AU  - Nagashima T
AU  - Ito YM
AU  - Atsumi T
PY  - 2024
JO  - BMJ open
DO  - 10.1136/bmjopen-2024-084846
UR  - https://doi.org/10.1136/bmjopen-2024-084846
ER  -

APA

N, M., D, N., S, N., KY, C., T, M., N, K., R, Y., J, Y., M, S., M, M., S, I., K, I., Y, I., A, K., J, Y., T, K., T, N., YM, I., & T, A. (2024). Effects of canagliflozin on brain natriuretic peptide levels in patients with type 2 diabetes on peritoneal dialysis in Japan: protocol for a multicentre, prospective, randomised controlled trial (CARD-PD trial).. BMJ open. https://doi.org/10.1136/bmjopen-2024-084846

Source records

pubmed · retrieved 2026-09-25T13:53:28.755Z